Fetal magnetic resonance imaging (MRI) has become a valuable second-line examination when ultrasound raises concern about a baby’s brain. It can add anatomical detail, clarify an uncertain finding and help a multidisciplinary team discuss likely outcomes before birth. The scan is particularly useful when the fetal position, maternal habitus, oligohydramnios or late gestation limits sonographic views.
For families in Australia, access usually sits within a specialist pathway involving a general practitioner, obstetrician, maternal-fetal medicine physician, radiologist and, where appropriate, a neonatologist or paediatric neurologist. The scientific context reflects the same perinatal priorities explored through the FAOPS 2020 congress site, where clinicians and researchers shared work across Asian and Oceania settings.
Ultrasound remains the first-line test for fetal brain assessment because it is accessible, dynamic and suitable for repeated examinations. It can identify ventriculomegaly, an absent or abnormal corpus callosum, posterior fossa changes, neural tube defects and many destructive lesions. MRI supplements that assessment rather than replacing it.
MRI provides a larger field of view and multiplanar images that are less affected by the skull and maternal tissues. It may show the extent of a haemorrhage, the pattern of cortical development, subtle differences between the cerebrum and cerebellum, or associated abnormalities outside the central nervous system. These details can change the diagnostic label and the counselling conversation.
The examination uses magnetic fields and radiofrequency energy, with no ionising radiation. Current clinical practice generally avoids gadolinium contrast in pregnancy, and fetal sedation is not routinely required. The mother usually lies comfortably on her back or side while rapid sequences are acquired, often within 20 to 45 minutes, depending on fetal movement and the protocol.
A referral is commonly made after an ultrasound detects moderate or severe ventriculomegaly, an abnormal midline structure, suspected agenesis of the corpus callosum, a small or malformed cerebellum, a possible neuronal migration disorder, intracranial cyst, tumour or haemorrhage. MRI can also be considered when ultrasound cannot answer a specific clinical question, rather than simply because a scan is difficult to interpret.
Timing depends on the suspected condition and gestational age. The fetal brain changes quickly, so a scan at 22 weeks cannot always answer the same questions as one at 32 weeks. Many centres perform MRI from around 20 to 22 weeks onwards, when the brain is sufficiently developed and the findings are likely to influence management. A repeat examination may be useful when a lesion evolves or the initial images are limited.
Additional indications include suspected congenital infection, complications in monochorionic twins, severe growth restriction with concern about brain injury and a family history of a recognised malformation syndrome. A referral should state the ultrasound findings and the question to be answered. That helps the radiologist tailor the protocol and avoids an unfocused scan.
Before the appointment, the imaging team explains the process, checks for relevant metal implants and reviews the ultrasound and clinical history. The mother does not usually need fasting. Ear protection is provided because the scanner is noisy, and communication with the technologist is maintained throughout. Fetal movement can reduce image quality, but modern sequences are designed to capture useful images quickly.
In Australia, pathways differ between state-funded tertiary hospitals and private imaging providers. A patient in Melbourne may be referred to the Royal Women’s Hospital, while a family in Sydney could attend a fetal medicine service linked with Westmead or another major maternity centre. Brisbane’s Mater Mothers’ Hospital and comparable services in Perth, Adelaide and Hobart also illustrate the concentration of advanced fetal imaging in metropolitan hospitals.
This concentration matters for rural and remote families. Travel from regional New South Wales, Queensland or Western Australia may involve several appointments, accommodation and time away from work or other children. Public hospitals may coordinate imaging and specialist review within one visit when possible, while private care can involve different referral and out-of-pocket arrangements. Medicare coverage and local hospital policies should be confirmed before booking.
MRI findings must be interpreted against gestational age. The fetal brain does not look static: sulcation becomes more complex, the ventricles may appear proportionally different and the cortical layers mature over time. A finding that is uncertain early in pregnancy may become clearer later, while some abnormalities only become apparent as development progresses.
For example, isolated mild ventriculomegaly has a different significance from ventriculomegaly accompanied by agenesis of the corpus callosum, cortical malformation, infection or chromosomal abnormalities. MRI can identify associated structural features that ultrasound misses, but it cannot reliably exclude every genetic or microscopic disorder. Amniocentesis, chromosomal microarray, targeted testing or infection studies may therefore remain relevant.
The value of the scan also depends on the quality of the clinical question. A report should describe the anatomy, confidence of the findings, technical limitations and any associated abnormalities. It should avoid presenting a probability as a certainty. Families benefit when the radiology report is reviewed in a meeting or consultation where imaging, genetics, obstetrics and neonatal care are considered together.
The prognostic value of fetal MRI is strongest when it refines a well-defined structural diagnosis. It can help estimate the likely severity of a brain malformation, identify features linked with developmental impairment and prepare the neonatal team for respiratory, feeding or seizure-related needs. It may also support decisions about delivery location, timing and postnatal investigations.
Still, imaging has limits. Brain function cannot be measured directly before birth, and outcomes vary among children with apparently similar anatomy. Cognitive development, motor skills, communication and epilepsy risk may be influenced by genetic factors, environmental factors, associated organ abnormalities and events after delivery. An apparently reassuring MRI reduces concern in some circumstances but does not guarantee typical development.
Counselling should use clear, balanced language. Families need to know what is known, what remains uncertain and whether the result is likely to change pregnancy management. Australian services may involve a fetal medicine specialist, genetic counsellor, social worker, neonatologist and paediatric neurologist. Cultural safety is especially important when discussing complex decisions with Aboriginal and Torres Strait Islander families, including time for family consultation and access to appropriate Aboriginal health support.
The wider perinatal environment also matters. Research discussed in the field includes relationships between maternal health, nutrition and later child development; relevant background can be found in maternal nutrition research. Such research should inform prevention and long-term care, but it should not be used to assign blame for an individual fetal brain anomaly.
A clear pathway begins with a detailed ultrasound and a written referral question. The treating team should explain why MRI is being recommended, what it may add and whether genetic or infection testing is also appropriate. Families should receive an opportunity to discuss the result after the scan rather than being left to interpret a technical report alone.
The decision about where to give birth may depend on the suspected condition. A pregnancy involving a severe brain anomaly or likely neonatal treatment may be best managed near a tertiary neonatal intensive care unit. For a regional family, this could mean temporary relocation to a capital city, supported by hospital social work, state travel assistance or local community services. The plan should include postnatal cranial ultrasound, MRI, neurological assessment and developmental follow-up when indicated.
| Clinical situation | What fetal MRI may add | Important limitation |
|---|---|---|
| Mild or moderate ventriculomegaly | Confirms ventricular size and looks for callosal, cortical or posterior fossa abnormalities | Prognosis depends heavily on associated findings and progression |
| Suspected agenesis of the corpus callosum | Defines the corpus callosum and searches for other brain or body anomalies | An isolated appearance does not predict one uniform developmental outcome |
| Possible cortical malformation | Assesses sulcation and brain organisation more closely | Very early or subtle abnormalities may remain invisible before birth |
| Intracranial haemorrhage or injury | Estimates distribution, timing and involvement of brain tissue | The functional effect may remain uncertain until postnatal assessment |
| Suspected congenital infection | Identifies ventriculomegaly, calcification-related changes, growth effects and destructive lesions | MRI cannot replace maternal testing, amniocentesis or newborn evaluation |
| Posterior fossa abnormality | Clarifies the cerebellum, vermis, brainstem and surrounding spaces | Small measurement differences can be difficult to interpret across gestation |
Fetal MRI is most useful when it is integrated into expert care rather than treated as a standalone verdict. Clinicians should document the indication, explain the limits of prediction and give families a realistic plan for the remaining pregnancy and the newborn period. Families and care teams can use this information to arrange timely referral, obtain an expert review and make informed decisions about birth and follow-up.